Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

Food and Healthcare Press Releases Monday March 19, 2018 10:08
AUSTIN, Texas--19 Mar--PRNewswire/InfoQuest

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia and Latin America, as well as experts from across the United States, attended the two-day educational conference in Austin, Texas. Attendees included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.

EPLive 2018 used live and recorded cases with expert commentary as the primary teaching tool. Cases were broadcast from some of the world's premier treatment centers, such as TCAI, Mayo Clinic, Stanford University Medical Center, Mount Sinai Hospital, UCLA Health System, the University of Pennsylvania Health System, University of Texas Southwestern Medical Center, University of Colorado Hospital, Vanderbilt Heart and Vascular Institute, Lancaster General Hospital and Massachusetts General Hospital.

The conference featured demonstrations by Dr. Andrea Natale, F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI and EPLive course director, as well as a number of TCAI physicians including course co-director Dr. Amin Al-Ahmad, Dr. Rodney Horton, Dr. Patrick Hranitzky, Dr. Robert Canby, Dr. Joseph Gallinghouse, Dr. Shane Bailey, Dr. Javier Sanchez, Dr. David Burkhardt, Dr. Jason Zagrodzky and Dr. Luigi DiBiase.

"EPLive is designed to bring the world's top cardiac electrophysiology physicians and researchers together to share the latest advances in interventional cardiac electrophysiology, as well as the tools and technology required to safely and effectively treat patients with heart rhythm disorders," Dr. Natale said. "Ultimately, this allows us to significantly improve outcomes for patients worldwide."

EPLive 2018 provided attending physicians with a better understanding of techniques used to treat atrial and ventricular arrhythmias, as well as implant complex devices and extract malfunctioning devices. Cases included procedures such as atrial fibrillation (A Fib) ablation, ventricular tachycardia (VT) ablation, epicardial and endocardial VT ablation, left atrial appendage closures, lead extraction and venoplasty.

EPLive 2018 also featured new technology, such as the Confirm Rx(TM) Insertable Cardiac Monitor (ICM) , the world's first and only smartphone-compatible monitor designed to help doctors identify even the most difficult-to-detect cardiac arrhythmias, and the CardioInsight(TM) vest , a noninvasive, 3-D mapping system worn by patients to collect chest ECG signals. Doctors then combine the signals with CT scan data to identify abnormal heart rhythms.

Physicians received a maximum of 18 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit(TM) hours at the conference.
For more information, visit EPLiveSymposium.com .
Media Contacts:
Erin Ochoa and Tina Shively
Elizabeth Christian Public Relations
+1.512.472.9599
Video - https://www.youtube.com/watch?v=dV-iU4U_1dI

Latest Press Release

Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in...

UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says

Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care. Poor oral health...

Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology

- Collaboration agreement enables Merck access to Iktos AI technology across three drug discovery projects - Generative modelling AI technology enables rapid and cost-effective design of novel drugs - Agreement is part of Merck's R&D strategy to...

Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment

Oxford Nanopore has today made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme. Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing...

FDI: Endodontics White Paper Calls for Treatment to Consider Impact on Patient Health and Well-being

FDI World Dental Federation (FDI) released its first white paper on endodontic care today, providing an important resource for dentists, national dental associations (NDAs) and other oral health actors. (Logo:...

Related Topics